Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-01

Clinical Trial Update: Individual Patient Compassionate Use of Nirogacestat

View source ↗

Summary

The document reports that nirogacestat is available for individual patient compassionate use in Desmoid Tumor and NOTCH gene mutation–positive tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nirogacestat (nirogacestat)

Snippet

Sponsor: SpringWorks Therapeutics, Inc. | Conditions: Desmoid Tumor, NOTCH Gene Mutation Positive Tumors | Status: AVAILABLE